From: Somatostatin receptor PET/CT in restaging of typical and atypical lung carcinoids
Parameter | Patients (N = 27) |
---|---|
Age (years) | 63.6/53.0–71.0 |
Gender | |
Female | 18 (66.7 %) |
Male | 9 (33.3 % |
Histopathology | |
TC | 12 (44.4 %) |
AC | 15 (55.6 %) |
Initial TNM staging (available for 19 patients) | |
T1 | 9 (47.4 %) |
T2 | 9 (47.4 %) |
T3 | 1 (5.3 %) |
N0 | 15 (78.9 %) |
N1 | 3 (15.8 %) |
Nx | 1 (5.3 %) |
M0 | 12 (63.2 %) |
M1 | 5 (26.3 %) |
Mx | 2 (10.5 %) |
IASCL stage at initial diagnosis [27] (available for 19 patients) | |
Stage Ia | 8 (42.1 %) |
Stage Ib | 5 (26.3 %) |
Stage IIa | 1 (5.3 %) |
Stage IV | 5 (26.3 %) |
Resection status | |
R0 | 20 (74.1 %) |
R1 | 2 (7.4 %) |
Unresected | 5 (18.5 %) |